Latest FDA Stories
Results Lead To Crucial Decision from Federal Agency BALTIMORE, May 22, 2015 /PRNewswire-USNewswire/ -- As a result of research performed by scientists at the University of Maryland School
MENLO PARK, Calif., May 22, 2015 /PRNewswire/ -- Nevro Corp.
Statistically Significant Findings Identify Key Efficacy Targets for Phase IIb/III Clinical Trial with RGN-259 ROCKVILLE, Md., May 22, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals,
SOPs for the 21st Century is a highly-interactive, two-day workshop that will teach the practical techniques needed for writing fast-read, flexible and compliant SOPs — SOPs that will meet FDA
Following Approval of the First Biosimilar in the U.S., Physician Groups Urge FDA to Give Full Consideration to Inclusion of Critical Information Needed by Physicians WASHINGTON, May 21, 2015
The First, Once-Daily, Extended-Release Amphetamine-based Oral Liquid for the Treatment of ADHD MONMOUTH JUNCTION, N.J., May 21, 2015 /PRNewswire/ -- Tris Pharma, Inc.
Venus Concept becomes the first and only company to receive FDA clearance for facial skin ablation and resurfacing by delivering Nano-Fractional Radio Frequency via SmartScan™ technology with
Senior Care Pharmacy Coalition (SCPC) Seeks to Preserve Patient Safety Practices, Align Requirements Across Federal Agencies WASHINGTON, May 20, 2015 /PRNewswire-USNewswire/ -- A new comment
The New "Mercy TAPE" Estimates Pediatric Weight with Greater Accuracy, Giving Doctors a Better Tool for Determining Prescription Dosage ROCKVILLE, Md., May 20, 2015 /PRNewswire/ --
Device is Initially Indicated for Non-Invasive Lipolysis of Flanks; Company Targeting U.S.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.